Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

[1]  C. Barnstable,et al.  HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration , 2006, Science.

[2]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[3]  Ronald Klein,et al.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.

[4]  Jennifer I. Lim,et al.  NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE , 2005, Retina.

[5]  L. Yannuzzi,et al.  NATURE AND RISK OF NEOVASCULARIZATION IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL RETINAL ANGIOMATOUS PROLIFERATION , 2005, Retina.

[6]  N. Yoshimura.  Polypoidal Choroidal Vasculopathy , 2004 .

[7]  A. Tamakoshi,et al.  Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan , 2004, International Ophthalmology.

[8]  Haitao Li,et al.  Polypoidal choroidal vasculopathy in elderly Chinese patients , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. , 2003, Archives of ophthalmology.

[10]  Irene Barbazetto,et al.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.

[11]  Y. Nose,et al.  Risk factors for age related maculopathy in a Japanese population: the Hisayama study , 2003, The British journal of ophthalmology.

[12]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[13]  E. Neoh,et al.  Polypoidal choroidal vasculopathy in Chinese patients , 2002, The British journal of ophthalmology.

[14]  Paul Mitchell,et al.  Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.

[15]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: natural history. , 2002, American journal of ophthalmology.

[16]  S. Harding.  Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials¿TAP Report No. 5 , 2002 .

[17]  J. Slakter,et al.  RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.

[18]  Y. Kiyohara,et al.  Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study , 2001, The British journal of ophthalmology.

[19]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[20]  Kanji Takahashi,et al.  The second eye of Japanese patients with unilateral exudative age related macular degeneration , 2000, The British journal of ophthalmology.

[21]  A. Bird,et al.  Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments , 2000 .

[22]  L A Yannuzzi,et al.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. , 1999, Archives of ophthalmology.

[23]  Kanji Takahashi,et al.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients. , 1999, A M A Archives of Ophthalmology.

[24]  Jennifer I. Lim,et al.  SYMPTOMATIC AGE‐RELATED MACULAR DEGENERATION IN ASIAN PATIENTS , 1996, Retina.

[25]  L. Yannuzzi,et al.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. , 1997, Archives of ophthalmology.

[26]  Judith Alexander,et al.  Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. , 1997, Archives of ophthalmology.

[27]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[28]  M. C. Leske,et al.  Features of Age-Related Macular Degeneration in a Black Population , 1995 .

[29]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[30]  Johannes R. Vingerling,et al.  The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.

[31]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1995, Retina.

[32]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[33]  Y. Ohnishi,et al.  Formation of drusen in the human eye. , 1986, American journal of ophthalmology.